fda 503a bulks list bpc-157 category 2 1 vs. Category 2. The FDA's peptide update, explained. Category peptides are on the FDA's “difficult to compound” list, which effectively blocks licensed pharmacies from producing them. Category 1 means Peptides: Legal and Regulatory Risks
Description
Most symptoms are reversible, although long-standing neurological damage may be permanent


Our clinic follows strict protocols

There is a theoretical --- though as yet unproven in humans --- risk that long-term or high-dose use could stimulate growth in existing malignant or pre-malignant cells
